Stem cells as the root of pancreatic ductal adenocarcinoma

被引:37
作者
Balic, Anamaria [1 ]
Dorado, Jorge [1 ]
Alonso-Gomez, Mercedes [1 ]
Heeschen, Christopher [1 ]
机构
[1] Spanish Natl Canc Res Ctr CNIO, Stem Cell & Canc Grp, Clin Res Programme, Madrid 28029, Spain
关键词
Pancreatic cancer; Cancer stem cells; Tumor-initiating cells; Inflammation; Targeted therapy; CIRCULATING TUMOR-CELLS; HEDGEHOG PATHWAY; CANCER-CELLS; SIGNALING PATHWAYS; DOWN-REGULATION; MOUSE MODEL; C-MET; CXCR4; GEMCITABINE; EXPRESSION;
D O I
10.1016/j.yexcr.2011.11.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Emerging evidence suggests that stem cells play a crucial role not only in the generation and maintenance of different tissues, but also in the development and progression of malignancies. For the many solid cancers, it has now been shown that they harbor a distinct subpopulation of cancer cells that bear stem cell features and therefore, these cells are termed cancer stem cells (CSC) or tumor-propagating cells. CSC are exclusively tumorigenic and essential drivers for tumor progression and metastasis. Moreover, it has been shown that pancreatic ductal adenocarcinoma does not only contain one homogeneous population of CSC rather than diverse subpopulations that may have evolved during tumor progression. One of these populations is called migrating CSC and can be characterized by CXCR4 co-expression. Only these cells are capable of evading the primary tumor and traveling to distant sites such as the liver as the preferred site of metastatic spread. Clinically even more important, however, is the observation that CSC are highly resistant to chemo- and radiotherapy resulting in their relative enrichment during treatment and rapid relapse of disease. Many laboratories are now working on the further in-depth characterization of these cells, which may eventually allow for the identification of their Achilles heal and lead to novel treatment modalities for fighting this deadly disease. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:691 / 704
页数:14
相关论文
共 50 条
  • [31] An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma
    Zhang, Tianpeng
    Gu, Zongting
    Ni, Ran
    Wang, Xiao
    Jiang, Qitao
    Tao, Ran
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (12):
  • [32] Targeting dendritic cells in pancreatic ductal adenocarcinoma
    Anton Deicher
    Roland Andersson
    Bobby Tingstedt
    Gert Lindell
    Monika Bauden
    Daniel Ansari
    Cancer Cell International, 18
  • [33] ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice
    Kimura, Yoshito
    Fukuda, Akihisa
    Ogawa, Satoshi
    Maruno, Takahisa
    Takada, Yutaka
    Tsuda, Motoyuki
    Hiramatsu, Yukiko
    Araki, Osamu
    Nagao, Munemasa
    Yoshikawa, Takaaki
    Ikuta, Kozo
    Yoshioka, Takuto
    Wang, Zong
    Akiyama, Haruhiko
    Wright, Christopher V.
    Takaori, Kyoichi
    Uemoto, Shinji
    Chiba, Tsutomu
    Seno, Hiroshi
    GASTROENTEROLOGY, 2018, 155 (01) : 194 - +
  • [34] The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells
    Momeny, Majid
    Esmaeili, Fatemeh
    Hamzehlou, Sepideh
    Yousefi, Hassan
    Javadikooshesh, Sepehr
    Vahdatirad, Vasimeh
    Alishahi, Zivar
    Mousavipak, Seyedeh H.
    Bashash, Davood
    Dehpour, Ahmad R.
    Tavangar, Seyyed M.
    Tavakkoly-Bazzaz, Javad
    Haddad, Peiman
    Kordbacheh, Farzaneh
    Alimoghaddam, Kamran
    Ghavamzadeh, Ardeshir
    Ghaffari, Seyed H.
    CELLULAR ONCOLOGY, 2019, 42 (04) : 491 - 504
  • [35] SMAD4 Loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells
    Chen, Yu-Wen
    Hsiao, Pi-Jung
    Weng, Ching-Chieh
    Kuo, Kung-Kai
    Kuo, Tzu-Lei
    Wu, Deng-Chyang
    Hung, Wen-Chun
    Cheng, Kuang-Hung
    BMC CANCER, 2014, 14
  • [36] Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma
    Roy, Ishan
    Boyle, Kathleen A.
    Vonderhaar, Emily P.
    Zimmerman, Noah P.
    Gorse, Egal
    Mackinnon, A. Craig
    Hwang, Rosa F.
    Franco-Barraza, Janusz
    Cukierman, Edna
    Tsai, Susan
    Evans, Douglas B.
    Dwinell, Michael B.
    LABORATORY INVESTIGATION, 2017, 97 (03) : 302 - 317
  • [37] Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma
    Nimmakayala, Rama Krishna
    Leon, Frank
    Rachagani, Satyanarayana
    Rauth, Sanchita
    Nallasamy, Palanisamy
    Marimuthu, Saravanakumar
    Shailendra, Gautam K.
    Chhonker, Yashpal S.
    Chugh, Seema
    Chirravuri, Ramakanth
    Gupta, Rohitesh
    Mallya, Kavita
    Prajapati, Dipakkumar R.
    Lele, Subodh M.
    C. Caffrey, Thomas
    L. Grem, Jean
    Grandgenett, Paul M.
    Hollingsworth, Michael A.
    Murry, Daryl J.
    Batra, Surinder K.
    Ponnusamy, Moorthy P.
    ONCOGENE, 2021, 40 (01) : 215 - 231
  • [38] Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics
    Tanase, Cristiana Pistol
    Neagu, Ana Iulia
    Necula, Laura Georgiana
    Mambet, Cristina
    Enciu, Ana-Maria
    Calenic, Bogdan
    Cruceru, Maria Linda
    Albulescu, Radu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10790 - 10801
  • [39] MicroRNA Signaling Pathway Network in Pancreatic Ductal Adenocarcinoma
    Sun, Longhao
    Chua, Corrine Ying Xuan
    Tian, Weijun
    Zhang, Zhixiang
    Chiao, Paul J.
    Zhang, Wei
    JOURNAL OF GENETICS AND GENOMICS, 2015, 42 (10) : 563 - 577
  • [40] Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A
    Del Aguila, Eduardo Mere
    Tang, Xiao-Han
    Gudas, Lorraine J.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (05) : 291 - 298